Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)

SHE:300006 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	5,121	5,427	3,865	3,928	4,023	7,201
Market Cap Growth	26.96%	40.44%	-1.61%	-2.36%	-44.14%	19.33%
Enterprise Value	4,577	4,900	3,221	3,425	3,734	6,886
Last Close Price	4.85	5.14	3.66	3.72	3.81	6.82
Forward PE	-	139.34	139.34	139.34	139.34	139.34
PS Ratio	6.60	7.00	4.86	4.39	4.55	5.88
PB Ratio	2.90	3.08	2.05	1.85	1.84	3.26
P/TBV Ratio	3.24	3.44	2.34	2.11	2.11	3.59
P/FCF Ratio	-	-	36.32	176.84	-	103.43
P/OCF Ratio	196.68	208.44	20.89	48.18	70.41	66.51
PEG Ratio	-	0.25	0.25	0.25	0.25	0.25
EV/Sales Ratio	5.90	6.32	4.05	3.82	4.22	5.62
EV/EBITDA Ratio	-	-	-	391.02	-	-
EV/FCF Ratio	-377.71	-	30.28	154.20	-	98.90
Debt / Equity Ratio	0.21	0.21	0.26	0.13	0.17	0.10
Debt / EBITDA Ratio	-	-	-	16.86	-	-
Debt / FCF Ratio	-	-	4.65	12.19	-	3.15
Net Debt / Equity Ratio	-0.31	-0.31	-0.31	-0.27	-0.22	-0.15
Net Debt / EBITDA Ratio	45.20	45.20	22.50	-64.58	13.63	5.36
Net Debt / FCF Ratio	45.60	45.60	-5.43	-25.47	43.53	-4.88
Asset Turnover	0.29	0.29	0.28	0.30	0.30	0.40
Inventory Turnover	1.89	1.89	1.59	1.52	1.33	1.68
Quick Ratio	1.82	1.82	1.90	2.57	2.15	2.32
Current Ratio	2.09	2.09	2.21	2.93	2.49	2.59
Return on Equity (ROE)	-6.94%	-6.94%	-4.00%	-0.46%	-3.47%	-6.15%
Return on Assets (ROA)	-1.37%	-1.37%	-1.63%	-1.19%	-2.21%	-2.75%
Return on Invested Capital (ROIC)	-4.71%	-4.72%	-5.22%	9.70%	-5.92%	-6.69%
Return on Capital Employed (ROCE)	-3.20%	-3.20%	-3.60%	-2.40%	-4.50%	-5.90%
Earnings Yield	-2.63%	-2.48%	-2.27%	-0.23%	-1.71%	-1.40%
FCF Yield	-0.24%	-0.22%	2.75%	0.56%	-0.27%	0.97%
Buyback Yield / Dilution	-0.03%	-0.03%	-0.48%	0.48%	-6.03%	-22.54%
Total Shareholder Return	-0.03%	-0.03%	-0.48%	0.48%	-6.03%	-22.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.